Pharma Focus Asia
KP - Choose our fully recyclable blister films

Local Production Of Pharmaceuticals And Related Technology Transfer In Developing Countries


As stakeholders in the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPA-PHI) adopted by the World Health Assembly in 2008,1 the United Nations Conference on Trade and Development (UNCTAD), the World Health Organization (WHO) and the International Centre for Trade and Sustainable Development (ICTSD) are collaborating on a project funded by the European Union (EU) to identify the main challenges and obstacles to local production in developing countries, with particular reference to technology transfer issues, and providing evidence- based recommendations on their feasibility and sustainability. As part of its contribution to this project, UNCTAD was responsible for undertaking this series of case studies designed to examine the transfer of technology and local production of pharmaceuticals in different regions, highlighting different characteristics such as firm structure, the means by which local producers obtained and developed the technological capacity to produce medicines, and the types of product handled, among others.

The case studies complement other activities of WHO and ICTSD under this project, which include a stakeholder analysis, regional dialogues and a trends survey, with a view to identifying perceived obstacles to acquiring and developing technology, enabling local production and identifying means to overcoming these obstacles.

This series of case studies also complements UNCTAD’s ongoing work in the areas of technology transfer, investment and local pharmaceutical production. The case studies make an important contribution to a recommendation by UNCTAD’s Commission on Investment, Technology and Related Financial Issues. This recommendation states that UNCTAD should, within its work programme on investment, technology, transfer and intellectual property, assess ways in which developing countries can develop their domestic productive capability in the supply of essential drugs in cooperation with pharmaceutical companies.  By giving concrete examples of successful technology transfer initiatives in the area of pharmaceutical production, the case studies provide a number of important lessons for policy-makers and other stakeholders in both developing and developed countries on issues of investment, science, technology and innovation, and intellectual property rights.

Download '.pdf' Format of the Case Study.

Download Casestudies
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayMerck - Mobius® productsThermo Fisher Scientific - Peptones5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024